Simplex Trading, LLC Magenta Therapeutics, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.62 - $0.79 $1,999 - $2,547	-3,225 Reduced 99.51%	16 $0
Q1 2023 Apr 27, 2023	BUY	$0.41 - $0.86 $1,328 - $2,787	3,241 New	3,241 $2,000
Q3 2022 Nov 04, 2022	SELL	$1.26 - $2.09 $321 - $532	-255 Reduced 13.4%	1,648 $2,000
Q2 2022 Aug 03, 2022	BUY	$0.97 - $3.08 $1,629 - $5,174	1,680 Added 753.36%	1,903 $2,000
Q1 2022 May 02, 2022	SELL	$2.55 - $5.23 $290 - $596	-114 Reduced 33.83%	223 $0
Q4 2021 Feb 23, 2022	BUY	$4.43 - $8.33 $1,492 - $2,807	337 New	337 $1,000
Q1 2021 Apr 26, 2021	SELL	$7.66 - $13.38 $10,670 - $18,638	-1,393 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$6.1 - $7.94 $14,993 - $19,516	-2,458 Reduced 63.83%	1,393 $10,000
Q3 2020 Oct 14, 2020	BUY	$6.52 - $8.94 $22,194 - $30,431	3,404 Added 761.52%	3,851 $26,000
Q2 2020 Jul 13, 2020	BUY	$6.18 - $10.76 $2,317 - $4,035	375 Added 520.83%	447 $3,000
Q1 2020 Apr 29, 2020	SELL	$6.03 - $15.24 $2,598 - $6,568	-431 Reduced 85.69%	72 $0
Q4 2019 Feb 05, 2020	BUY	$9.07 - $15.84 $4,562 - $7,967	503 New	503 $7,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.